The Growth in Legal Cannabis Market Sales

Tuesday, March 14, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, March 14, 2017 /PRNewswire/ --

FinancialBuzz.com News Commentary

According

to Arcview Market Research, the regulated cannabis sales in North America totaled $6.9 billion in 2016, which is a 30 percent increase from 2015. Sales are projected to increase to
$21.6 billion
by the year 2021, representing a 26 percent compound annual growth rate. The data also points out that if sales from the illegal markets are included in the calculations, then cannabis consumers in the United States and Canada spent over $53 billion in 2016. The difference in these sales figures indicate the potential strength if the legalization process and decriminalization of cannabis continues. CURE Pharmaceutical Holding Corp. (OTC: CURR), Axim Biotechnologies Inc. (OTC: AXIM), General Cannabis Corporation (OTC: CANN), Cannabis Sativa Inc. (OTC: CBDS), Medicine Man Technologies Inc. (OTC: MDCL)

Troy Dayton, CEO of Arcview Market Research said in a statement, "The enormous amount of existing, if illicit, consumer spending sets cannabis apart from most other major consumer-market investment opportunities throughout history; the cannabis industry doesn't need to create demand for a new product or innovation - it just needs to move demand for an already widely-popular product into legal channels."

CURE Pharmaceutical Holding Corp. (OTCQB: CURR) announced yesterday after the market closed that, the U.S. Patent and Trademark Office (USPTO) has granted Patent #9,561,182, covering the method of manufacture and method of use of the company's proprietary oral thin film technology, for the administration of medicaments in order to treat animals. 

"This patent adds an important aspect to our intellectual property portfolio, as it now ensures many of the same protections we enjoy in human products to animal products, which can be used in a variety of contexts, from households with pets to farms," said Rob Davidson, CEO of CURE Pharmaceutical. "This is also further validation of our unique approach to the development of oral thin film and our proprietary CureFilm technology."

"This action also represents an important expansion in the methodology, veterinarians may have, moving forward to deliver important medicines to the animals for whom they care," added Greg Strathe, DVM, CURE Pharmaceutical advisory board member, and co-owner SAHO, Small Animal Hospital of Owasso, Okla. "The expansion of our ability to improve care continues to be a priority for those in veterinary medicine, and I believe that this approach is a true innovation."

Axim Biotechnologies Inc. (OTCQB: AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. Its flagship products include CanChew PlusŪ, a CBD-based controlled release chewing gum, and MedChew RxŪ; a combination CBD/THC gum, that will be undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. Axim Biotechnologies recently enrolled 40 patients to begin Phase II Trial, for the treatment of Irritable Bowel Syndrome (IBS) with CanChew PlusŪ cannabidiol chewing gum. Selected from a pool of over 400 patients, 40 trial patients aged 18-65 will be subject to a randomized, double-blind, cross-over trial of 8 weeks. Patients will receive a maximum 6 chewing gums per day, either containing 50 mg of cannabidiol per chewing gum, in case of the CanChew chewing gum, or a placebo chewing gum.

General Cannabis Corporation (OTCQB: CANN) is a resource company for the highest quality service providers, available to the regulated Cannabis Industry. The company lease growing space and related facilities, such as commercial real estate and equipment, to licensed marijuana business operators for their production needs. Also, they pursue ancillary business products, regulatory compliance consulting, and advanced logistical support for grow operations. Its subsidiary, Iron Protection Group, provides security and training services to government agencies, multinational corporations, diplomats, dignitaries and non-profit organizations, both domestic and abroad. Iron Protection Group encompasses all things related to protection, from training individuals in the art of manipulating a firearm, all the way to providing a personal security detail for any security needs.

Cannabis Sativa Inc. (OTCQB: CBDS) through its subsidiaries, develops, manufactures, and sells herbal based skin care products in the United States and internationally. It offers herbal based line of products, such as Go Deep, a deep penetrating healing salve that reduces pain and inflammation when massaged into muscles, ligaments, tendons, and joints; Go Deep EXTRA, a deep penetrating pain relief ointment for use in mitigating migraine and sinus headaches; Face Garden, an antioxidant and moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also engages in the research, development, and licensing of natural cannabis products comprising cannabis formulations, edibles, topicals, strains, recipes, and delivery systems.

Medicine Man Technologies Inc. (OTCQB: MDCL) provides consulting services for cannabis growing technologies and methodologies, as well as retail operations of cannabis products. The Company focuses on providing assistance to its clients, in various businesses related to the cannabis industry, including cultivation; the dispensary business model, including combinations and other variables related to the retail model configuration of both a medical, as well as adult use (recreational) operation, and other areas, including but not limited to business plan generation, financial pro forma generation, application generation support, recommendations for other service providers, employee training and facility design services. It offers a separate cultivation or dispensary license and other related consultative services. It offers both pre-license consulting, as well as licensure services that generally tie to the size of the proposed business venture.

Please Sign Up Now at http://www.FinancialBuzz.com to Receive Alerts on Trending Financial News from all these companies. 'The Latest Buzz in Financial News'

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook like us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com 

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. Financialbuzz.com has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. FinancialBuzz.com only regurgitates financial or corporate news through our unique financial newswire and media platform. FinancialBuzz.com has been compensated a total of eight thousand dollars for financial news dissemination and pr services by a third party non affiliate for cure pharmaceutical holding corp. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information: Media Contact: E-mail: info@financialbuzz.com Phone: +1-877-601-1879

URL: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook